LC
Louise Chen Scotiabank Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
13
Avg Return
Past Year
Past Year
23%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
57.1%
Neutral
42.9%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mega Cap
Over $200B
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Financials
Healthcare
Financials
Financial Data & Stock Exchanges
Healthcare
Biotechnology
Diagnostics & Research
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
Medical Devices
Medical Instruments & Supplies
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Sector Outperform
Maintained
| $177 |
19%
upside
| 2 | +10% |
0
%
| 11 Feb ‘26 27 days ago |
|
|
|
Sector Outperform
Maintained
| $40 |
27%
upside
| 2 | +5.5% |
0
%
| 29 Jan ‘26 1 month ago |
|
|
|
Sector Outperform
Maintained
| $265 |
8%
upside
| 1 | +12% |
0
%
| 22 Jan ‘26 1 month ago |
|
|
|
Sector Perform
Maintained
| $60 |
1%
downside
| 2 | – |
–
| 9 Jan ‘26 2 months ago |
|
|
|
Sector Outperform
Maintained
| $120 |
2%
upside
| 1 | +15% |
0
%
| 4 Dec ‘25 3 months ago |
|
|
|
Sector Perform
Maintained
| $770 |
1%
downside
| 1 | – |
–
| 24 Nov ‘25 3 months ago |
|
|
|
Sector Outperform
Upgraded
| $80 |
356%
upside
| 2 | -55% |
0
%
| 6 Jun ‘25 9 months ago |
|
|
|
Sector Perform
Downgraded
| $135 |
4%
upside
| 1 | +14% |
–
| 2 Jun ‘25 9 months ago |
|
|
|
Sector Outperform
Maintained
| $9 |
145%
upside
| 1 | +179% |
0
%
| 9 May ‘25 10 months ago |
|
|
|
Sector Perform
Downgraded
| $14 |
52%
downside
| 1 | -45% |
–
| 3 Apr ‘25 11 months ago |
|